Related Experiment Video
Updated: Feb 25, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Cell Cycle Synchronization of HeLa Cells to Assay EGFR Pathway Activation
1Signal Transduction Research Group, Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Abstract:
Progression through the cell cycle causes changes in the cell's signaling pathways that can alter EGFR signal transduction. Here, we describe drug-derived protocols to synchronize HeLa cells in various phases of the cell cycle, including G1 phase, S phase, G2 phase, and mitosis, specifically in the mitotic stages of prometaphase, metaphase, and anaphase/telophase. The synchronization procedures are designed to allow synchronized cells to be treated for EGF and collected for the purpose of Western blotting for EGFR signal transduction components.S phase synchronization is performed by thymidine block, G2 phase with roscovitine, prometaphase with nocodazole, metaphase with MG132, and anaphase/telophase with blebbistatin. G1 phase synchronization is performed by culturing synchronized mitotic cells obtained by mitotic shake-off. We also provide methods to validate the synchronization methods. For validation by Western blotting, we provide the temporal expression of various cell cycle markers that are used to check the quality of the synchronization. For validation of mitotic synchronization by microscopy, we provide a guide that describes the physical properties of each mitotic stage, using their cellular morphology and DNA appearance. For validation by flow cytometry, we describe the use of imaging flow cytometry to distinguish between the phases of the cell cycle, including between each stage of mitosis.
Insights
This study details drug-based methods to synchronize HeLa cells for studying epidermal growth factor receptor (EGFR) signaling during the cell cycle. These protocols enable precise analysis of EGFR pathway components across different cell cycle phases.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cell cycle progression dynamically alters cellular signaling pathways.
- Epidermal growth factor receptor (EGFR) signal transduction is influenced by cell cycle phase.
- Understanding these dynamics requires synchronized cell populations.
Purpose of the Study:
- To establish robust drug-derived protocols for synchronizing HeLa cells across all cell cycle phases.
- To enable detailed investigation of EGFR signal transduction components in a cell cycle-dependent manner.
- To provide validated methods for assessing synchronization quality.
Main Methods:
- Utilized specific drugs for cell cycle arrest: thymidine (S phase), roscovitine (G2 phase), nocodazole (prometaphase), MG132 (metaphase), and blebbistatin (anaphase/telophase).
- Employed mitotic shake-off for G1 phase synchronization.
- Developed validation techniques including Western blotting for cell cycle markers, microscopy for mitotic morphology, and imaging flow cytometry for phase identification.
Main Results:
- Successfully synchronized HeLa cells in G1, S, G2, prometaphase, metaphase, and anaphase/telophase.
- Demonstrated temporal expression patterns of key cell cycle markers via Western blotting.
- Provided morphological and flow cytometry criteria for validating synchronization accuracy.
Conclusions:
- The described drug-based protocols offer reliable methods for cell cycle synchronization in HeLa cells.
- These synchronized populations facilitate precise analysis of EGFR signaling pathway dynamics.
- Validated synchronization techniques ensure experimental rigor and reproducibility.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
10:03Establishing a High Throughput Epidermal Spheroid Culture System to Model Keratinocyte Stem Cell Plasticity
Published on: January 30, 2021